We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

2884:TWSEE.SUN Financial Holding Co., Ltd. Analysis

Data as of 2026-03-11 - not real-time

¥994.00

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

Yoshimura Food Holdings is trading at ¥994, just below its 20‑day SMA of ¥998.75 and comfortably above the 50‑day (¥880) and 200‑day (¥865) averages, indicating a lingering bullish bias. However, the MACD histogram is negative and the MACD signal is bearish, volume has slipped to 30,700 shares versus a 10‑day average of 153,560, and 30‑day volatility is elevated at 47%, suggesting the price may test the near‑term support around ¥913 before resuming any upside toward the resistance at ¥1,066.
Fundamentally, the company posts modest revenue growth of 0.7% and thin profit margins (2.8% net), but it delivers a respectable ROE of 14% and a low forward PE of 11.8, while its price‑to‑sales ratio of 0.41 points to relative cheapness. The balance sheet is a concern: a debt‑to‑equity of 187% and total debt of ¥34.8 bn dwarf its cash of ¥13.4 bn, and operating and free cash flow are reported as zero, underscoring liquidity pressure. No dividend is paid, and the market sentiment is at “Extreme Greed” (76.9 on the Fear‑Greed Index), which may be inflating short‑term demand.
Given the mix of bullish technical positioning, bearish momentum signals, high leverage, and attractive valuation multiples, the stock sits in a delicate position. Investors should be cautious of a near‑term pullback, but the defensive consumer segment and undervalued pricing could support a longer‑term case if the company improves cash generation and reduces debt.

Market Outlook

Short Term

< 1 year
Cautious
Model confidence: 6/10

Key Factors

  • Bearish MACD and decreasing volume
  • High short‑term volatility
  • Proximity to support at ¥913

Medium Term

1–3 years
Neutral
Model confidence: 5/10

Key Factors

  • Defensive consumer sector providing stability
  • Attractive forward PE and price‑to‑sales ratios
  • Elevated debt levels limiting upside

Long Term

> 3 years
Positive
Model confidence: 7/10

Key Factors

  • Undervalued valuation multiples relative to peers
  • Solid ROE indicating efficient equity use
  • Potential for debt reduction and cash‑flow improvement

Key Metrics & Analysis

Financial Health

Revenue Growth0.70%
Profit Margin2.83%
P/E Ratio15.0
ROE14.03%
ROA3.25%
Debt/Equity187.55
P/B Ratio2.0

Technical Analysis

TrendBullish
RSI55.6
Support¥913.00
Resistance¥1,066.00
MA 20¥998.75
MA 50¥880.44
MA 200¥864.93
MACDBearish
VolumeDecreasing
Fear & Greed Index76.91

Valuation

GradeFair
TypeValue

Risk Assessment

Beta0.42
Volatility47.04%
Sector RiskLow
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskHigh

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.